The Medicines and Healthcare products Regulatory Agency (MHRA) is proud to announce its designation as a WHO-Listed Authority (WLA) by the World Health Organization (WHO), joining the ranks of the world’s most trusted regulatory bodies. This recognition affirms MHRA’s commitment to the highest international standards in the regulation of medical products and marks a significant milestone for the UK’s leadership in global health.

The designation places MHRA alongside Health Canada and Japan’s MHLW/PMDA as newly appointed WLAs announced by the WHO earlier today, reinforcing a growing network of 39 authorities whose work underpins faster, broader access to quality-assured medical products – especially in low- and middle-income countries.

This achievement is a testament to the UK’s strategic

See Full Page